Showing results (211-220 of 232) with videos related to
Sort By:
Pageof 24
The Lancet. Digital Health|March 11, 2022
Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.Annals of Internal Medicine|June 13, 2017
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c LevelsRichard M Bergenstal, Robin L Gal, Crystal G Connor, et al.Journal of Diabetes Science and Technology|March 18, 2024
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized TrialD Steven Fox, Julia Ware, Charlotte K Boughton, et al.Communications Medicine|April 6, 2024
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic reviewJamie L Felton, Maria J Redondo, Richard A Oram, et al.Journal of Diabetes Science and Technology|March 28, 2022
Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE StudyMichelle A Van Name, Lauren G Kanapka, Linda A DiMeglio, et al.Diabetes, Obesity & Metabolism|July 15, 2022
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parentsKorey K Hood, Natasha Garcia-Willingham, Sarah Hanes, et al.Diabetes|April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J Haller, S Alice Long, J Lori Blanchfield, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trialMark R Rigby, Linda A DiMeglio, Marc S Rendell, et al.The Journal of Clinical Investigation|July 21, 2015
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patientsMark R Rigby, Kristina M Harris, Ashley Pinckney, et al.Hormone Research in Paediatrics|January 8, 2016
Global Consensus Recommendations on Prevention and Management of Nutritional RicketsCraig F Munns, Nick Shaw, Mairead Kiely, et al.Pageof 24